1. Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis
   Dongdong Jiang et al, 2017, International Journal of Surgery CrossRef
2. Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy
   Chitra Rajagopal et al, 2018, Pharmacological Research CrossRef
3. Association between FOXM1 and hedgehog signaling pathway in human cervical carcinoma by tissue microarray analysis
   Hong Chen et al, 2016 CrossRef
4. MicroRNA-320 suppresses cervical cancer cell viability, migration and invasion via directly targeting FOXM1.
   Can Shi et al, 2017, Oncol Lett CrossRef
5. Integrated analysis of transcription factors and targets co-expression profiles reveals reduced correlation between transcription factors and target genes in cancer
   Jinsheng Liang et al, 2018, Funct Integr Genomics CrossRef
6. FAST1 promotes the migration and invasion of colorectal cancer cells
   Qiong Cheng et al, 2018, Biochemical and Biophysical Research Communications CrossRef
7. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation
   KanKan Yang et al, 2015, J Exp Clin Cancer Res CrossRef
8. A Structure-Activity Relationship Study of Forkhead Domain Inhibitors (FDI): the importance of halogen binding interactions
   Seyed Amirhossein Tabatabaei Dakhili et al, 2019, Bioorganic Chemistry CrossRef
9. Angioregulatory microRNAs in Colorectal Cancer
   Mohammad Hasan Soheilifar et al, 2019, Cancers CrossRef
10. FoxM1 and β-catenin predicts aggressiveness in Middle Eastern ovarian cancer and their co-targeting impairs the growth of ovarian cancer cells
    Poyil Pratheeshkumar et al, 2018, Oncotarget CrossRef
11. Overexpression of forkhead box M1 and urokinase‑type plasminogen activator in gastric cancer is associated with cancer progression and poor prognosis
    Jie Ma et al, 2017, Oncol Lett CrossRef
12. Silencing of FoxM1 blocks growth, migration and invasion of papillary thyroid carcinoma cells
    Xiaotao Wang et al, 2019, Oncol Lett CrossRef
13. miR‑34a inhibits esophageal squamous cell carcinoma progression via regulation of FOXM1
    Haibo Zhou et al, 2018, Oncol Lett CrossRef
14. Anti-cancer immunotherapy using cancer-derived multiple epitope-peptides cocktail vaccination clinical studies in patients with refractory/persistent disease of uterine cervical cancer and ovarian cancer [phase 2]
    Satoshi Takeuchi et al, 2020, OncoImmunology CrossRef
15. In Silico Analysis Guides Selection of BET Inhibitors for Triple-Negative Breast Cancer Treatment
    Javier Pérez-Peña et al, 2016, Mol Cancer Ther CrossRef
16. Cytotoxic activities of Hypericum perforatum L. extracts against 2D and 3D cancer cell models
    Ivana Z. Matić et al, 2021, Cytotechnology CrossRef
17. The Anticancer Effects of FDI-6, a FOXM1 Inhibitor, on Triple Negative Breast Cancer
    Karan Ulhaka et al, 2021, IJMS CrossRef
18. CDI Exerts Anti-Tumor Effects by Blocking the FoxM1-DNA Interaction
    Woo Dae Jang et al, 2022, Biomedicines CrossRef
19. Abnormal expression of FOXM1 in carcinogenesis of renal cell carcinoma: From experimental findings to clinical applications
    Yanmei Shan et al, 2023, Biochemical and Biophysical Research Communications CrossRef
20. Radiomics and Radiogenomics Toward Personalized Management of Clear Cell Renal Cell Carcinoma: The Importance of FOXM1
    Federico Greco et al, 2024, Academic Radiology CrossRef